Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 9.38% vs -0.67% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -229.78% vs -31.81% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is -1,159.26% vs -105.90% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 200.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
Compare Quarterly Results Of Wakamoto Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 9.38% vs -0.67% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 15.08% vs 1.30% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -229.78% vs -31.81% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -851.75% vs -111.31% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -1,159.26% vs -105.90% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -400.88% vs -72.97% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs 200.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 50.00% vs 100.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






